Abstract
Background
Primary biliary cirrhosis (PBC) is regarded as an autoimmune liver disease and familial clustering of PBC could represent some genetic predisposition to the disease.
Aims
To elucidate the genetic background of PBC by investigating familial cases of PBC.
Methods
Familial cases were picked out from 171 PBC patients who enrolled in this study. We analyzed them and their family members, and compared them clinically and immunogenetically to non-familial cases.
Results
Out of 171 PBC patients, ten (5.8%) were identified as familial PBC in five families. The clinical features of familial PBC were almost comparable to those of non-familial PBC. The distribution of human leukocyte antigens (HLA)-A, -B and -DR in familial PBC showed no specificity. Two new PBC patients were identified in one family in addition to the two originally enrolled PBC patients, resulting in four patients with PBC within the same family. The two new PBC patients had an identical HLA haplotype. On the other hand, one HLA-identical sister of a PBC patient in another family did not develop PBC.
Conclusions
Primary biliary cirrhosis can exhibit familial clustering without any HLA predisposition, however, a survey of families for PBC could be useful for identifying new patients with PBC in the asymptomatic stage for earlier diagnosis and treatment.
Similar content being viewed by others
References
Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–1273.
Tsuji K, Watanabe Y, Van de Water J, et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun. 1999;13:171–178.
Hayase Y, Iwasaki S, Akisawa N, et al. Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis. Hepatol Res. 2005;33:33–38.
Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974;290:63–69.
Tong MJ, Nies KM, Reynolds TB, Quismorio FP. Immunological studies in familial primary biliary cirrhosis. Gastroenterology. 1976;71:305–307.
Jaup BH, Zettergren LS. Familial occurrence of primary biliary cirrhosis associated with hypergammaglobulinemia in descendants: a family study. Gastroenterology. 1980;78:549–556.
Kato Y, Suzuki K, Kumagai M, et al. Familial primary biliary cirrhosis: immunological and genetic study. Am J Gastroenterol. 1981;75:188–191.
Cales P, Calot M, Voigt JJ, et al. Familial autoimmune pathology comprising two cases of primary biliary cirrhosis. Gastroenterol Clin Biol. 1983;7:777–784.
Chalmers EA, Chan Lam D, Holden RJ, Fitzimons EJ. Familial primary biliary cirrhosis and autoimmune thrombocytopenia. Scot Med J. 1987;32:152.
Tsuji H, Murai K, Akagi K, Fujishima M. Familial primary biliary cirrhosis associated with impaired concanavalin A-induced lymphocyte transformation in relatives. Dig Dis Sci. 1992;37:353–360.
Ramakrishna B, Eapen CE, Kang G, Kurian G, Chandy GM. Familial intrahepatic cholestatic cirrhosis with positive antimitochondrial antibody: familial primary biliary cirrhosis. J Clin Gastroenterol. 2000;30:255–258.
Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically based population study. J Hepatol. 1999;30:402–407.
Myszor M, James OF. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med. 1990;75:377–385.
Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 1995;36:615–617.
Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology. 1990;11:458–464.
Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol. 1994;20:698–701.
Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J Hepatol. 1997;26:737–740.
Bittencourt PL, Farias AQ, Abrantes-Lemos CP, et al. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2004;19:873–878.
Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology. 2007;46:785–792.
Abu-Mouch S, Selmi C, Benson GD, et al. Geographic clusters of primary biliary cirrhosis. Clin Dev Immunol. 2003;10:127–131.
Tanaka A, Borchers AT, Ishibashi H, Ansari AA, Keen CL, Gershwin ME. Genetic and familial considerations of primary biliary cirrhosis. Am J Gastroenterol. 2001;96:8–15.
Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194–1202.
Trowsdale J, Ragoussis J, Campbell RD. Map of the human MHC. Immunol Today. 1991;12:443–446.
Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 1999;42:1071–1079.
Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Baillière’s Clin Endocrinol Metab. 1995;9:631–656.
Tsao BP. Genetic susceptibility to lupus nephritis. Lupus. 1998;7:585–590.
Tanaka H, Akaza T, Juji T. Report of the Japanese central bone marrow data center. Clin Transpl. 1996; 139–144.
Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004;127:485–492.
Shiroi A, Yoshikawa M, Kinoshita K, et al. Primary biliary cirrhosis in a son and his father. Kanzo. 1998;39:335–339.
Galbraith RM, Eddleston ALWF, Smith MGM, et al. Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J. 1974;3:604–605.
Ercilla G, Pares A, Arriaga F, et al. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 1979;14:449–452.
Kato Y, Kumagai M, Kobayashi K, Hattori N, Sasazuki T. Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol. 1982;5:312–313.
Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 1983;26:213–217.
Liu HY, Deng AM, Zhou Y, Yao DK, Xu DX, Zhong RQ. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int. 2006;5:129–132.
Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology. 1992;16:1404–1408.
Gregory WL, Mehal W, Dunn AN, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med. 1993;86:393–399.
Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ. Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J Hepatol. 2002;36:126–129.
Wassmuth R, Depner F, Danielsson A, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens. 2002;59:381–387.
Invernizzi P, Selmi C, Poli F, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008;48:1906–1912.
Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens. 1994;43:71–77.
Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut. 2001;48:397–402.
Mullarkey ME, Stevens AM, McDonnell WM, et al. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens. 2005;65:199–205.
Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology. 2006;44:667–674.
Onishi S, Sakamaki T, Maeda T, et al. DNA typing of HLA class II genes: DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol. 1994;21:1053–1060.
Invernizzi P, Battezzati PM, Crosignani A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol. 2003;38:401–406.
Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yanagisawa, M., Takagi, H., Takahashi, H. et al. Familial Clustering and Genetic Background of Primary Biliary Cirrhosis in Japan. Dig Dis Sci 55, 2651–2658 (2010). https://doi.org/10.1007/s10620-009-1057-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-1057-0